BayMark Health Services Expands In-Office Opioid Treatment Services in Indiana | News


LEWISVILLE, TX, February 7, 2022 /PRNewswire-PRWeb/ — AppleGate Recovery, a BayMark Health Services company, announced the acquisition of Lucina Treatment Centers, a group of five office-based opioid treatment (OBOT) programs based in Central and Northeast Indiana. Founded in 2016, Lucina offers treatment and medication advice based on buprenorphine and Suboxone® in a doctor’s office. There are two Indianapolis locations in addition to locations in Kokomo, Muncie and Fort Wayne offering hope to those struggling with opioid addiction, which they will continue to do under the AppleGate Recovery service brand.

BayMark now operates 50 OBOT programs in 13 states providing outpatient treatment with buprenorphine and buprenorphine compounds such as the well-known brand Suboxone®. BayMark OBOT programs, known under the brand names AppleGate Recovery and Middlesex Recovery, provide a comprehensive, individualized treatment plan that alleviates physical withdrawal symptoms and psychological cravings to promote long-term recovery.

In addition to medication and counseling, these programs offer case management services and access to medical providers, counselors and staff who can guide patients to find the resources they need as they rebuild their lives. life. Ensuring the overall health of our patients is the number one priority.

Michael Saulpresident of AppleGate Recovery, said, “There is no state, county or city in this country that has not been impacted by the opioid epidemic. Indiana saw a 33% increase in drug overdose deaths from 2019 to 2020. We have seen similar increases across the country as the COVID-19 pandemic has impacted all of our lives. BayMark is proud to lend its expertise and support to these programs as they continue to do vital work in areas in dire need of opioid addiction treatment services. »

For more information about AppleGate Recovery and our services, visit:

About BayMark Health Services:

BayMark Health Services provides substance use disorder (SUD) treatment to over 72,000 recovering patients at over 350 treatment facilities in 36 states and 3 Canadian provinces. Largest provider of Opioid Use Disorder (OUD) services in North America and the leader in evidence-based treatment options for SUD, BayMark’s continuum of care includes medication therapy (MAT), withdrawal management, PHP, IOP, counseling and other supportive therapies innovative in ambulatory, hospitalization and establishment.

Media Contact

Robin JohnsonBayMark Health Services, 214.379.3303, [email protected]

SOURCE BayMark Health Services


Comments are closed.